Evidence map›Paper›PMID 27336684›Full record

ArticleJournal of medicinal chemistry2016

Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention.

Christian R Kowol, Walter Miklos, Sarah Pfaff, Sonja Hager, Sebastian Kallus, Karla Pelivan, Mario Kubanik, Éva A Enyedy, Walter Berger, Petra Heffeter and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of medicinal chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Novel Pyridine-Based Thiazolyl-Hydrazone as a Promising Attenuator ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Human serum albumin as a copper source for anticancer thiosemicarbazones.Metallomics : integrated biometal science · 2023
    Article
  7. Article
  8. Article
  9. Estrone-salicylaldehyde N-methylated thiosemicarbazone hybrids and their copper complexes: solution structure, stability and anticancer activity in tumour spheroids.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Synthesis, crystal structure and Hirshfeld analysis of a crystalline compound comprising a 1/1 mixture of 1-[(1Acta crystallographica. Section E, Crystallographic communications · 2020
    Article
  17. The thiosemicarbazone MeCell death & disease · 2018
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Christian R KowolInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
Walter MiklosInstitute of Cancer Research, Medical University of Vienna , Borschkeg. 8a, A-1090 Vienna, Austria.
Sarah PfaffInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
Sonja HagerInstitute of Cancer Research, Medical University of Vienna , Borschkeg. 8a, A-1090 Vienna, Austria.
Sebastian KallusInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
Karla PelivanInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
Mario KubanikInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
Éva A EnyedyDepartment of Inorganic and Analytical Chemistry, University of Szeged , Dóm tér 7, 6720 Szeged, Hungary.
Walter BergerInstitute of Cancer Research, Medical University of Vienna , Borschkeg. 8a, A-1090 Vienna, Austria.
Petra HeffeterInstitute of Cancer Research, Medical University of Vienna , Borschkeg. 8a, A-1090 Vienna, Austria.
Bernhard K KepplerInstitute of Inorganic Chemistry, University of Vienna , Waehringer Str. 42, A-1090 Vienna, Austria.
University of Vienna · ATMedical University of Vienna · ATUniversity of Szeged · HU

Funding

Austrian Science Fund FWF P 22072
6 · The paper itself

Abstract

One of the most promising classes of iron chelators are α-N-heterocyclic thiosemicarbazones with Triapine as the most prominent representative. In several clinical trials Triapine showed anticancer activity against hematological diseases, however, studies on solid tumors failed due to widely unknown reasons. Some years ago, it was recognized that "terminal dimethylation" of thiosemicarbazones can lead to a more than 100-fold increased activity, probably due to interactions with cellular copper depots. To better understand the structural requirements for the switch to nanomolar cytotoxicity, we systematically synthesized all eight possible N-methylated derivatives of Triapine and investigated their potential against Triapine-sensitive as well as -resistant cell lines. While only the "completely" methylated compound exerted nanomolar activity, the data revealed that all compounds with at least one N-dimethylation were not affected by acquired Triapine resistance. In addition, these compounds were highly synergistic with copper treatment accompanied by induction of reactive oxygen species and massive necrotic cell death.

Indexed as

Antineoplastic AgentsCell ProliferationCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorHumansMethylationMolecular StructurePyridinesStructure-Activity RelationshipThiosemicarbazonesTumor Cells, Cultured3-aminopyridine-2-carboxaldehyde thiosemicarbazoneAntineoplastic AgentsPyridinesThiosemicarbazones

Identifiers

PMID27336684
PMCPMC4966696
OpenAlexW2473254065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.